Status:
TERMINATED
Augmentation Cystoplasty Using an Autologous Neo-Bladder
Lead Sponsor:
Tengion
Conditions:
Neurogenic Bladder
Eligibility:
All Genders
3-21 years
Phase:
PHASE2
Brief Summary
Subjects with neurogenic bladder secondary to spina bifida refractory to medical treatment will be enrolled. The hypothesis is that augmentation cystoplasty using an autologous neo-bladder construct w...
Detailed Description
Subjects with neurogenic bladder secondary to spina bifida (myelodysplasia) that is refractory to medical treatment and require augmentation cystoplasty will be enrolled. The hypothesis is that augmen...
Eligibility Criteria
Inclusion
- subjects with neurogenic bladders secondary to myleodysplasia
Exclusion
- prior augment procedures
- recent urologic surgery
- requires concomitant urologic intervention
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00419120
Start Date
December 1 2006
End Date
April 1 2011
Last Update
November 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Childrens Hospital
Boston, Massachusetts, United States, 02115